Speakers
Content under construction.
|
Maria João Calheiros-Lobo |
Degree in Medicine (1985) and Dental Medicine (1989) - University of Porto, Portugal. Post-Graduation in Oral Implantology, Oral Surgery, Cosmetic Dentistry, Orthodontics and Chronobiology and Sleep Medicine. Mini-residency in Biomaterials and Adhesive Dental Medicine - University of Minnesota, USA. Invited Assistant Professor, since 1992, Conservative Dental Medicine Service (IUCS-CESPU). Researcher at FCT - PTDC/QUI/72683/2006; /WHO/5890/2004. Researcher at UNIPRO- Research Unit in Oral Pathology and Rehabilitation (IUCS-CESPU). Author and co-author of articles in international peer-reviewed journals in the field of salivary proteomics, and biomaterials in dental materials and oral rehabilitation (Scopus - Index h-12 and Index i10-13). Private clinical practice mainly in Dental Cosmetics, Implantology and Orthodontics.
|
|
Vanessa Marcelino |
PhD student in Biomedical Sciences UNIPRO - Oral Pathology and Rehabilitation Research Unit. Researcher in group UNIPRO- Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS-CESPU). Dentistry Integrated Master’s degree (IUCS-CESPU). Invited assistant at the University Institute of Health Sciences (IUCS-CESPU). Orthodontic Clinical Course - Trevisi Zanelato MBT Philosophy. Post-graduate Diploma in Interceptive Orthodontics (IUCS-CESPU).
|
|
Júlio Fonseca |
Licenced in Dentistry in 2004 by the Department of Dentistry - Faculty of Medicine, University of Coimbra, Portugal. Post-Graduated in Oral Prosthetic Rehabilitation by the Department of Dentistry - Faculty of Medicine, University of Coimbra, Portugal. Master in Experimental Patology - Faculty of Medicine, University of Coimbra, Portugal (thesis in the Bruxism area). PhD in Temporomandibular Disorders at the Faculty of Medicine, University of Coimbra, Portugal, 2020. Invited Assistant until 2015 of the disciplines of Dental Anatomy, Fisiology of the Stomatognatic System, and Occlusal Rehabilitation of the Integrated Master in Dentistry of the Department of Dentistry - Faculty of Medicine, University of Coimbra, Portugal. Vice-President of the ´´Sociedade Portuguesa de Disfunção Temporomandibular e Dor Orofacial’’ (SPDOF) between 2014-2018. President of the ´´Sociedade Portuguesa de Disfunção Temporomandibular e Dor Orofacial’’ (SPDOF) between 2018-2021. Vice-President of the Sleep Section of the ´´Sociedade Portuguesa de Disfunção Temporomandibular e Dor Orofacial’’ (SPDOF) since 2014. Member of the Deontologic Council of the Portuguese Dental Association. Member of the OMD Sector Skills Monitoring Committee. Author and Co-Author of several articles and presentations published/presented in national or international cientific journals and congresses. Conferencist and lecturer of several Courses in Prosthodontics, Oro-Facial Pain and Temporo-Mandibular Disorders areas. Private Practice in Prosthodontics, Orofacial Pain and Temporomandibular Disorders.
|
|
Fernando Exposto |
DDS - Instituto Superior Ciências de Saúde Egas Moniz (ISCSEM), Portugal (2007). American Board of Orofacial Pain (ABOP) diplomate. Master in Dental Sciences - Danube University, Krems, Austria (2010-2012). Orofacial Pain residency, University of Kentucky, Lexington, USA (2013-2015). Master in Headache Disorders – Danish Headache Center, Copenhagen, Denmark (2016-2018). PhD fellow, Section of Orofacial Pain and Jaw Function, Department of Dentistry and Oral Health, Aarhus University, Denmark (2016 - 2019) Assistant Professor, Section of Orofacial Pain and Jaw Function, Department of Dentistry and Oral Health, Aarhus University, Denmark (2021 – present). Diplomate of the American Board of Orofacial Pain since 2016. 31 peer-reviewed publications. H-index 9 (Scopus). Citations: 203 (Scopus, May 2023).
|
|
Victor LLoro |
|
|
Ana Lúcia Messias |
Assistant professor – Faculty of Medicine, University of Coimbra. Member of the EAO Editorial Office Committee. Member of CEMMPRE – Center for Mechanical Engineering, Materials and Processes, University of Coimbra. Member of LBIM – Bioinformatics and Medical Statistics Laboratory.
|
|
Fernando Ferreira |
|
|
Saman Warnakulasuriya |
Professor Warnakulasuriya is an emeritus professor of Oral Medicine and Experimental Pathology at King’s College London, UK and was the Chairman of the Oral Medicine Division at King’s College Hospital and at Guy’s Hospital, London between 2005 -2015. He has made major contributions to cancer epidemiology, oral medicine and clinical trials. He is a leading expert on human carcinogens, especially tobacco, alcohol and areca nut that cause mouth cancer. His early work showed that smokeless tobacco and areca nut cause cancers of the mouth and have led the International Agency on Research on Cancer to confirm these substances as Class 1 carcinogens and to re-affirm an Europe-wide ban on smokeless tobacco use. Professor Warnakulasuriya has also been involved in developing the terminology and classification of oral potentially malignant disorders and studied their natural history and molecular changes during progression to malignancy. He has made substantial contributions to the world literature. Research interests: Epidemiology, natural history, screening and molecular markers of oral cancer and pre-cancer.
|
|
Alexander Ross Kerr |
Dr. Ross Kerr received his DDS from McGill University in Montreal, Canada, and his MSD and certificate in Oral Medicine at the University of Washington. He is a Clinical Professor and the Director of Oral Medicine in the Department of Oral & Maxillofacial Pathology, Radiology & Medicine at New York University College of Dentistry and the recipient of NYU’s distinguished teaching award. He is a past president of the American Academy of Oral Medicine, secretary of the American Board of Oral Medicine, steering committee member of the World Workshop on Oral Medicine, member of the executive committee of the European Association of Oral Medicine, and member of the Scientific Advisory Board for the Oral Cancer Foundation. His research experience includes the evaluation of current and emerging technologies for the detection and diagnosis of oral cancer and oral potentially malignant disorders. He has contributed more than 100 publications to the dental and medical literature.
|
|
Juan Seonane |
Professor in Oral Surgery, University of Santiago de Compostela. Coordinator of the National Campaigns for the Prevention of Oral Cancer of the Spanish Dental Council. Past-president and current member of the Continuing Education Commission of the Spanish Dental Council. Academic in the medical-surgical section of the National Academy of Dental Sciences of Spain. Author of more than 200 scientific articles in the field of oral pathology.
|
|
Alan Roger Santos-Silva |
Doctor of Dental Surgery (São Paulo State University, UNESP, Brazil) and specialist in Oral Medicine and Oral Pathology (Brazilian Federal Dental Council); Master of Science in Oral Medicine and PhD in Pathology at Piracicaba Dental School, The University of Campinas (UNICAMP, Brazil) and visiting researcher at the School of Clinical Dentistry (Oral & Maxillofacial Department), University of Sheffield, England. Oral Medicine specialist at the São Paulo State Cancer Institute (ICESP, São Paulo University Medical School; 2010-2011) and currently holds the position of Associate Professor in the Oral Diagnosis Department at UNICAMP. Coordinator of the Graduate Program (MSc and PhD courses) in Oral Medicine and Pathology at UNICAMP [CAPES 6 (2012-2016)]; Member of the academic Working Groups of the World Workshop on Oral Medicine VIII (American Academy of Oral Medicine) and the International Agency for Research on Cancer (IARC) Handbooks of Cancer Prevention to produce Volume 19 entitled "Oral Cancer Prevention" that will be edited by the World Health Organization (WHO). e-mails: alan@unicamp.br; alanroger@hotmail.com
|
|
Luís Lima |
Luís Lima is a highly qualified researcher with extensive experience in cancer biomarkers. He obtained a BSc in Applied Biology from the University of Minho in 2005, an MSc in Molecular Medicine and Oncology from the Medical Faculty of the University of Porto in 2008, and a PhD in Biomedical Sciences from the Abel Salazar Biomedical Sciences Institute from the University of Porto in 2014. His research career began during his BSc studies, where he focused on studying microsatellite instability and loss of heterozygosity on chromosome in bladder cancer. During his MSc dissertation, he investigated the role of FAS/FASL genetic polymorphism on prostate cancer susceptibility. In his PhD, he developed a predictive model of BCG therapy response in bladder cancer using genetic polymorphisms and tumor-associated biomarkers. As a postdoctoral researcher, he worked with the Experimental Pathology and Therapeutics Group from CI-IPOP in collaboration with the Glycobiology in Cancer group, IPATIMUP, i3S. During this time, he focused on identifying glycobiomarkers as targets for bladder cancer chemoresistant cells and evaluating the role of circulating tumor cells (CTCs) in gastrointestinal cancer. In 2020, as a Junior Researcher, he started leading a research line and a team (currently with four members, two PhD and two MSc students) in cancer biomarkers, specifically in the role of CTCs in cancer management and more recently in fecal biomarkers for CRC screening. Lima has published over 35 research papers, with an h-index of 19 and a total citation count of 1435. Additionally, he has authored two book chapters, has one registered patent, and has supervised/co-supervised two PhD theses and seven MSc dissertations. Furthermore, he has participated in five projects as a fellow and researcher, and currently an exploratory project granted by FCT and a European project, where he is also a co-PI. Overall, Luís Lima is a highly accomplished and skilled researcher with a strong focus on cancer biomarkers and an impressive track record in academia.
|
|
Lúcio Lara Santos |
Lucio Lara Santos. Completed the Title of Aggregate in Medical Sciences in 2019 by the Abel Salazar Institute of Biomedical Sciences of the University of Porto, PhD in Medicine in 2003 by the Faculty of Medicine of the University of Porto, Master in Oncobiology in 1993 by the Faculty of Medicine of the University of Porto and Doctor in Medicine in 1985 from the Faculty of Medicine of Agostinho Neto University (Angola). At the Portuguese Institute of Oncology of Porto Francisco Gentil EPE, he is a member of the Scientific Council of the IPOFG-CRP, a member of the Antibiotics Committee of the Department of Oncological Surgery, a member of the group responsible for the Oncological Registry, Coordinator of the Hepato-bilio-pancreatic Surgery Unit from the Digestive Pathology Clinic, Research Coordinator of the Experimental Pathology and Therapeutics group and Director of the Intermediate Care Unit. Currently, he is an Associate Professor at the Abel Salazar Institute of Biomedical Sciences of the University of Porto, Associate Professor at the Fernando Pessoa University, and he also develops teaching activities at 4 more universities in the country. He adds activities as a collaborator at the Institute for Research and Innovation in Health, as well as at the Research and Studies Center of the Fernando Pessoa University. At the present time he has more than 156 publications in specialist journals, having written 13 book chapters and 7 books in the field of Oncology and Dentistry. He adds to this curriculum several missions in Guinea-Bissau, Angola, Cape Verde and Mozambique, in coordination with national and international entities, with the aim of improving cancer care in those countries.
|
|
António Mata |
Full Professor; PhD in Biology, Oral Biology speciality; UICOB - Biomedical and Oral Sciences Research Unit; Research Group: GIBBO; Area of Interest: Oral Biochemistry, Oral Biology, Oral Medicine, Evidence Based Dentistry.
|
|
Marta Relvas |
Graduate in Dentistry in 2002 by Cooperativa de Ensino Superior Politécnico e Universitário, completed the Master in Public Health in 2005 by Oporto University -School of Medicine, and Doktor (PhD) in Scientific advances in dentistry in 2012 by the University of Santiago de Compostela. Published 14 articles in journals and is the author of several poster papers at national and international congresses. Supervised 17 MSc dissertation(s). Has received 4 awards and/or honors. Principal investigator in 3 project(s) and Researcher in 3 project(s). Works in the area(s) of Medical and Health Sciences with emphasis on Health Sciences. Specialist in Periodontology and is an assistant Profesor at IUCS. He is a member of UNIPRO.
|
|
Ana Sofia Vinhas |
1991-1997 |Degree in Dentistry (IUCS – CESPU); 2007-2010 | Master in Periodontology (IUCS – CESPU); 2016 | Specialty College of Periodontology of the Order of Dentists; 2019/09-2023/01 | Universidad de Sevilla: Sevilla, ES; Phd in Oral Pathology and Health: Local and systemic implications (Department of Stomatology Faculty of Dentistry of the University of Seville); 1997-2023 |DMD Professor on IUCS-CESPU; 2018/01-2023 | Coordination of Post-graduated Programm of Clinical Periodonics and Peri-implantology.
|
|
James Hoying |
James (Jay) Hoying is a Partner and Chief Scientist at Advanced Solutions Life Sciences (ASLS) with more than 30 years of experience in basic and applied biological sciences with a focus in tissue biology, tissue vascularization, and tissue fabrication. At ASLS, he directs an active laboratory developing a variety of advanced, vascularized human tissue models and tissue therapeutics. Prior to joining ASLS, he was Professor and Chief of the Division of Cardiovascular Therapeutics at the Cardiovascular Innovation Institute (CII) where he developed a broad background in tissue fabrication, cell therapeutics, and translation of discoveries to industry and the clinic. Dr. Hoying is an inventor of the Angiomics® vascularization technology and holds numerous patents related to vascularizing tissues and related cell-based therapies.
|
